Patents by Inventor Didier Cussac

Didier Cussac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEQUITAZINE FOR TREATING OR PREVENTING PATHOLOGIES INVOLVING HISTAMINE H4 RECEPTORS
    Publication number: 20100273752
    Abstract: The present application relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, 10-[(3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine or 10-[(3R,3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, or a pharmaceutically acceptable salt thereof, to prepare a drug to prevent or treat pathologies involving histamine H4 receptor.
    Type: Application
    Filed: December 4, 2008
    Publication date: October 28, 2010
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Thierry Clerc, Christophe Przybylski, Jacky Tisne-Versailles, Didier Cussac
  • Cyclobutaindolecarboxamide compounds
    Patent number: 6743818
    Abstract: A compound selected from those of formula (I): wherein: n represents integer from 0 to 6, R1 represents a group selected from hydrogen, hydroxy, cyano, alkoxy, alkoxycarbonyl, carboxy, optionally substituted aminocarbonyl, and NR4R5 wherein R4, and R5 are as defined in the description, R2 represents a group selected from hydrogen, alkyl, hydroxymethyl, and —U—V—W wherein T, U, V, and W are as defined in the description, and R3 represents a group selected from hydrogen, linear or branched (C1-C6)alkyl, aryl, and, heteroaryl, its isomers, and also addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful in the treatment of CNS disorders.
    Type: Grant
    Filed: July 12, 2002
    Date of Patent: June 1, 2004
    Assignee: Les Laboratoires Servier
    Inventors: Jean-Louis Peglion, Bertrand Goument, Mark Millan, Françoise Lejeune, Didier Cussac
  • Cyclobutaindolecarboxamide compounds
    Publication number: 20030032812
    Abstract: A compound selected from those of formula (I): 1
    Type: Application
    Filed: July 12, 2002
    Publication date: February 13, 2003
    Inventors: Jean-Louis Peglion, Bertrand Goument, Mark Millan, Francoise Lejeune, Didier Cussac
  • Cyano-indole serotonin-reuptake inhibitor compound
    Patent number: 6492366
    Abstract: A compound selected from those of formula (I): wherein: R1 and R2 each independently represent hydrogen or, alkyl, T1 and T2 each independently represent alkylene, G represents a heterocyclic group selected of formula (&agr;):  wherein: W1 to W5 and X1 to X4 are so defined in the description. Medicinal products containing the same are useful as serotonin-reuptake inhibitors.
    Type: Grant
    Filed: October 11, 2000
    Date of Patent: December 10, 2002
    Assignee: Les Laboratoires Servier
    Inventors: Gilbert Lavielle, Olivier Muller, Mark Millan, Didier Cussac, Anne Dekeyne
  • Cyclobutaindolecarboxamide compounds
    Patent number: 6452015
    Abstract: A compound selected from those of formula (I): wherein: n represents integer from 0 to 6, R1 represents a group selected from hydrogen, hydroxy, cyano, alkoxy, alkoxycarbonyl, carboxy, optionally substituted aminocarbonyl, and NR4R5 wherein R4, and R5 are as defined in the description, R2 represents a group selected from hydrogen, alkyl, hydroxymethyl,  and -U-V-W wherein T, U, V, and W are as defined in the description, and R3 represents a group selected from hydrogen, linear or branched (C1-C6)alkyl, aryl, and, heteroaryl, its isomers, and also addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful in the treatment of CNS disorders.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: September 17, 2002
    Assignee: Les Laboratoires Servier
    Inventors: Jean-Louis Peglion, Bertrand Goument, Mark Millan, Françoise Lejeune, Didier Cussac
  • Cyclobutaindolecarboxamide compounds
    Publication number: 20010044426
    Abstract: A compound selected from those of formula (I): 1
    Type: Application
    Filed: April 12, 2001
    Publication date: November 22, 2001
    Inventors: Jean-Louis Peglion, Bertrand Goument, Mark Millan, Francoise Lejeune, Didier Cussac